1990年畢業(yè)于防衛(wèi)醫(yī)科大學(xué)

1993年完成美國潛艇部隊(duì)醫(yī)學(xué)課程(美國潛艇部隊(duì)的醫(yī)學(xué)水平在呼吸統(tǒng)疾病方面處于世界領(lǐng)頭水平)

1999年國立癌癥中心中央醫(yī)院呼吸外科醫(yī)師

2007年國立癌癥中心中央醫(yī)院呼吸外科主任

2008年順天堂大學(xué)醫(yī)學(xué)部呼吸外科學(xué)教授

日本外科學(xué)會指導(dǎo)醫(yī)、外科專門醫(yī)

日本呼吸外科學(xué)會指導(dǎo)醫(yī)

日本肺癌學(xué)會會員

順天堂大學(xué)醫(yī)學(xué)部呼吸外科講座主任教授

日本胸外科學(xué)會正式會員、評議員

日本呼吸外科學(xué)會評議員

日本肺癌學(xué)會評議員

美國臨床腫瘤學(xué)會(ASCO)正式會員

歐洲胸外科學(xué)會(ESTS)正式會員

世界肺癌會議(IASLC)會員

AATS 正式會員

日本呼吸內(nèi)窺鏡學(xué)會會員

胸外科醫(yī)師學(xué)會(STS) 會員

歐洲心胸外科協(xié)會 (EACTS) 會員

1997年 世界肺癌學(xué)會(IASLC) Young investigator award

1998年 美國臨床腫瘤學(xué)會(ASCO) Merit award

1999年　日本肺癌學(xué)會　篠井?河合獎

2004年　日本癌癥學(xué)會　癌癥學(xué)會鼓勵獎

2005年　高松宮妃癌癥研究基金獎勵

2009年　日本呼吸外科學(xué)會獎

2015年　順天堂大學(xué)醫(yī)學(xué)部最佳教授獎

2016年　順天堂大學(xué)醫(yī)學(xué)部最佳教授獎

1. Togo S, Katagiri N, Namba Y, et al. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients. Oncotarget 2017; 8(21): 34884-95.

2. Takamochi K, Mogushi K, Kawaji H, et al. Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma. PloS one 2017; 12(4): e0175622.

3. Takamochi K, Imashimizu K, Fukui M, et al. Utility of Objective Chest Tube Management After Pulmonary Resection Using a Digital Drainage System. Ann Thorac Surg 2017; 104(1): 275-83.

4. Tachi R, Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. The impact on the prognosis of unsuspected N2 disease in non-small-cell lung cancer: indications for thorough mediastinal staging in the modern era. Surg Today 2017; 47(1): 20-6.

5. Suzuki K, Watanabe S, Wakabayashi M, et al. A Non-randomized Confirmatory Phase III Study of Sublobar Surgical Resection for Peripheral Ground Glass Opacity Dominant Lung Cancer Defined with Thoracic Thin-section Computed Tomography (JCOG0804/WJOG4507L). Proceeding of the American Society of Clinical Oncology 2017.

6. Matsunaga T, Suzuki K, Takamochi K, Oh S. What is the radiological definition of part-solid tumour in lung cancer?dagger. Eur J Cardiothorac Surg 2017; 51(2): 242-7.

7. Kitamura Y, Suzuki K, Teramukai S, et al. Feasibility of Pulmonary Resection for Lung Cancer in Patients With Coronary Artery Disease or Atrial Fibrillation. Ann Thorac Surg 2017; 103(2): 432-40.

8. Ichikawa T, Saruwatari K, Mimaki S, et al. Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia. Lung Cancer 2017; 113: 134-9.

9. Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Surgical Management of Multifocal Ground-Glass Opacities of the Lung: Correlation of Clinicopathologic and Radiologic Findings. Thorac Cardiovasc Surg 2017; 65(2): 142-9.

10. Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer. Ann Thorac Surg 2017; 103(5): 1614-20.

11. Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Locoregional recurrence after segmentectomy for clinical-T1aN0M0 radiologically solid non-small-cell lung carcinoma. Eur J Cardiothorac Surg 2017; 51(3): 518-25.

12. Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Surgical resection for clinical-Stage I radiological pure-solid lung cancer that met the current high risk criteria. Jpn J Clin Oncol 2017: 1-9.

13. Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer. Ann Thorac Surg 2017; 104(1): 313-20.

14. Hattori A, Matsunaga T, Takamochi K, Oh S, Suzuki K. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma. J Thorac Cardiovasc Surg 2017.

15. Hattori A, Matsunaga T, Hayashi T, Takamochi K, Oh S, Suzuki K. Prognostic Impact of the Findings on Thin-Section Computed Tomography in Patients with Subcentimeter Non-Small Cell Lung Cancer. J Thorac Oncol 2017; 12(6): 954-62.

16. Hara K, Saito T, Hayashi T, et al. Inverse correlation between galectin-4 and TTF-1 in lung adenocarcinoma. Virchows Archiv : an international journal of pathology 2017.

17. Fukui M, Takamochi K, Oh S, et al. Study on Perioperative Administration of a Neutrophil Elastase Inhibitor for Interstitial Pneumonias. Ann Thorac Surg 2017; 103(6): 1781-7.

18. Fukui M, Suzuki K, Matsunaga T, Oh S, Takamochi K. Surgical intervention for ground glass dominant lesions: observation or outright resection? Jpn J Clin Oncol 2017: 1-6.

19. Aokage K, Yoshida J, Hishida T, et al. Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review. Jpn J Clin Oncol 2017; 47(1): 7-11.

20. Aokage K, Okada M, Suzuki K, et al. Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery. Jpn J Clin Oncol 2017; 47(2): 190.

鈴木健司教授與厚樸方舟（北京）健康管理有限公司 簽約建立深度合作關(guān)系。

資料來源：

【1】順天堂大學(xué)醫(yī)學(xué)部附屬順天堂醫(yī)院呼吸外科：

https://www.juntendo.ac.jp/hospital/clinic/kokyukigeka/about/staff.html

【2】時事メディカルのサービス：https://medical.jiji.com/doctor/1545

【3】Medical Note：https://medicalnote.jp/doctors/180323-002-HZ

【4】醫(yī)療新聞：https://www.jmnn.jp/archives/29258